Profile
Jonas Frick is currently the Chairman at Frick Management AB, Director at A. Carlsson Research AB, Nordic Water Products AB, AB Inventech A, and Founding Partner at Alder AB. He is a former President & Chief Executive Officer at Medivir AB, Chief Executive Officer at Resistentia Pharmaceuticals AB, Scandinavian Life Science Ventures AB, and Non-Executive Director at Elan Corp.
Plc.
He was also the Chairman at Newron Sweden AB and DermaGen AB. Additionally, he served as a Director at Gyros AB, Doxa AB, Jernforsen Energi System AB, and r2p GmbH.
He was a Principal at Pharmacia AB. Frick completed his undergraduate degree at the University of Uppsala.
Jonas Frick active positions
| Companies | Position | Start |
|---|---|---|
Frick Management AB | Chairman | 05/04/2011 |
The Swedish Biotechnology Industry Organization | Corporate Officer/Principal | 11/04/2011 |
Alder AB
Alder AB Investment ManagersFinance Alder is an active, long-term manager which aims to develop strong environmental technology companies by investing in established and profitable companies with growth potential. Their geographic focus is on the Nordic region. The firm seeks to invest in established high growth companies with turnover of SEK 30-500 million, partnering with investee management to provide management and corporate governance skills, including recruiting board members. Alder seeks to exit transactions by company sales or listing on a recognized stock exchange. | Private Equity Investor | 13/05/2010 |
Nordic Water Products AB
Nordic Water Products AB Industrial MachineryProducer Manufacturing Provides equipment and systems for water and wastewater treatment | Director/Board Member | - |
AB Inventech A/S
AB Inventech A/S Wholesale DistributorsDistribution Services Provides special purpose machineries | Director/Board Member | - |
Former positions of Jonas Frick
| Companies | Position | End |
|---|---|---|
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Develops and discovery and clinical development of new pharmacological treatment principles for psychiatric and neurological disorders | Director/Board Member | 31/12/2021 |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Director/Board Member | 26/05/2011 |
Resistentia Pharmaceuticals AB
Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops immunotherapy products | President | 24/06/2010 |
Scandinavian Life Science Ventures AB
Scandinavian Life Science Ventures AB Investment ManagersFinance SLS Invest is an active manager which provides financing for early, later, and growth-stage capital requirements, as well as providing management support. The firm targets companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. It invests in young companies located in Northern Europe and the United States, and looks to take both minority and majority stake positions in its investments, as well as a seat on the board. | President | 01/10/2007 |
| ░░░░░░░ ░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Training of Jonas Frick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Gyros AB
Gyros AB Medical SpecialtiesHealth Technology Engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays | Health Technology |
The Swedish Biotechnology Industry Organization | |
Medivir AB
Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pharmacia AB
Pharmacia AB Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Resistentia Pharmaceuticals AB
Resistentia Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops immunotherapy products | Health Technology |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Doxa AB
Doxa AB Medical SpecialtiesHealth Technology Develops, manufactures, and commercializes bio ceramic dental products | Health Technology |
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Develops and manufactures therapeutic drugs for central nervous system disorders | Health Technology |
Scandinavian Life Science Ventures AB
Scandinavian Life Science Ventures AB Investment ManagersFinance SLS Invest is an active manager which provides financing for early, later, and growth-stage capital requirements, as well as providing management support. The firm targets companies operating in the health technology sector, and industries such as biotechnology and pharmaceuticals. It invests in young companies located in Northern Europe and the United States, and looks to take both minority and majority stake positions in its investments, as well as a seat on the board. | Finance |
A. Carlsson Research AB
A. Carlsson Research AB Pharmaceuticals: MajorHealth Technology Develops and discovery and clinical development of new pharmacological treatment principles for psychiatric and neurological disorders | Health Technology |
DermaGen AB
DermaGen AB Pharmaceuticals: MajorHealth Technology Develops therapeutic peptides | Health Technology |
Jernforsen Energi System AB
Jernforsen Energi System AB Electric UtilitiesUtilities Develops and manufactures bio fuel heating plants | Utilities |
Nordic Water Products AB
Nordic Water Products AB Industrial MachineryProducer Manufacturing Provides equipment and systems for water and wastewater treatment | Producer Manufacturing |
Frick Management AB | |
Alder AB
Alder AB Investment ManagersFinance Alder is an active, long-term manager which aims to develop strong environmental technology companies by investing in established and profitable companies with growth potential. Their geographic focus is on the Nordic region. The firm seeks to invest in established high growth companies with turnover of SEK 30-500 million, partnering with investee management to provide management and corporate governance skills, including recruiting board members. Alder seeks to exit transactions by company sales or listing on a recognized stock exchange. | Finance |
r2p GmbH
r2p GmbH Other TransportationTransportation Develops integrated public transportation systems and technologies | Transportation |
AB Inventech A/S
AB Inventech A/S Wholesale DistributorsDistribution Services Provides special purpose machineries | Distribution Services |
- Stock Market
- Insiders
- Jonas Frick
















